Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction

NCT02356146 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT02356146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02356146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction
Lead sponsor
Chulalongkorn University
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
June 30, 2015
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation recipients